Breast Biopsy Devices Market Size To Cross USD 4.6 Bn By 2030

The global breast biopsy devices market size accounted for US$ 2.96 Bn in 2022 and is projected to reach around USD 4.6 Bn by 2030, growing at a CAGR of 5.67% from 2022 to 2030.

Report Summary

The global breast biopsy devices market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the breast biopsy devices market across the globe.

A comprehensive estimate on the breast biopsy devices market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of breast biopsy devices during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2402

Breast Biopsy Devices Market  Report Scope 

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized breast biopsy devices market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Dermatology CRO Market Size To Cross USD 8.7 Bn By 2030

Breast Biopsy Devices Market Players

The report includes the profiles of key breast biopsy devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

• Cook Medical Incorporated
• Becton, Dickinson and Company
•  Devicor Medical Products Inc.
• C.R. Bard, Inc., Hologic Inc
• Argon Medical Devices
• Planmed OY
• Encapsule Medical Devices LLC
• Ethicon Endo-Surgery (Johnson and Johnson)

Market Segmentation

By Product

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kits
• Liquid Biopsy Instruments
• Others

By Guidance

• Image-Guided Biopsy
• Mammography-guided Stereotactic Biopsy
• Ultrasound-guided Biopsy
• MRI-guided Biopsy
• Other Guidance Techniques
• Liquid Biopsy
• NGS-based Biopsy
• PCR-based Biopsy
• Microarray-based Biopsy

By Type

• Needle Breast Biopsy
• Core Needle Biopsy (CNB)
• Fine Needle Aspiration Biopsy (FNAB)
• Vacuum-assisted Biopsy (VAB)
• Open Surgical Breast Biopsy
• Excisional
• Incisional
• Liquid Breast Biopsy
• Circulating Tumor Cells
• Circulating Tumor DNA (CtDNA)
• Other Biomarkers

Regional Segmentation

• North America (U.S., Canada, Mexico)
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
• Latin America (Brazil and Rest of Latin America)
• Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
• In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Breast Biopsy Devices Market 

5.1. COVID-19 Landscape: Breast Biopsy Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Breast Biopsy Devices Market, By Product

8.1. Breast Biopsy Devices Market, by Product, 2022-2030

8.1.1 Biopsy Needles

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Guidance Systems

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Biopsy Tables

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Localization Wires

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Assay Kits

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Liquid Biopsy Instruments

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Others

8.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Breast Biopsy Devices Market, By Guidance

9.1. Breast Biopsy Devices Market, by Guidance, 2022-2030

9.1.1. Image-Guided Biopsy

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Mammography-guided Stereotactic Biopsy

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Mammography-guided Stereotactic Biopsy

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. MRI-guided Biopsy

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Other Guidance Techniques

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Liquid Biopsy

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. NGS-based Biopsy

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. PCR-based Biopsy

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Microarray-based Biopsy

9.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Breast Biopsy Devices Market, By Type 

10.1. Breast Biopsy Devices Market, by Type, 2022-2030

10.1.1. Needle Breast Biopsy

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Core Needle Biopsy (CNB)

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Fine Needle Aspiration Biopsy (FNAB)

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Vacuum-assisted Biopsy (VAB)

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Open Surgical Breast Biopsy

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Excisional

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Incisional

10.1.7.1. Market Revenue and Forecast (2017-2030)

10.1.8. Liquid Breast Biopsy

10.1.8.1. Market Revenue and Forecast (2017-2030)

10.1.9. Circulating Tumor Cells

10.1.9.1. Market Revenue and Forecast (2017-2030)

10.1.10. Circulating Tumor DNA (CtDNA)

10.1.10.1. Market Revenue and Forecast (2017-2030)

10.1.11. Other Biomarkers

10.1.11.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Breast Biopsy Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.1.3. Market Revenue and Forecast, by Type (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Type (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Type (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.2.3. Market Revenue and Forecast, by Type (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Type (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Type (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Type (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Type (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.3.3. Market Revenue and Forecast, by Type (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Type (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Type (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Type (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Type (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.4.3. Market Revenue and Forecast, by Type (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Type (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Type (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Type (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Type (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.5.3. Market Revenue and Forecast, by Type (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Type (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Guidance (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Type (2017-2030)

Chapter 12. Company Profiles

12.1. Cook Medical Incorporated

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Becton, Dickinson and Company

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Devicor Medical Products Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. C.R. Bard, Inc., Hologic Inc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Argon Medical Devices

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Planmed OY

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Encapsule Medical Devices LLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Ethicon Endo-Surgery (Johnson and Johnson)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com